Page 1

Alembic Touching Lives over 100 years ALEMBIC PHARMACEUTICALS LIMITED CIN : L24230GJ2010PLC061123 Regd.Office : Alembic Road , Vadodara 390 003 Tel : 0265 2280550 Email apl.investors@alembic.co.in Website : www.alembicpharmaceuticals.com Statement of Consolidated Unaudited Financial Results for the quarter and half year ended 30th September , 2021 . Quarter Ended 1 Revenue from Operations 2 Other Income 3 Total Income Expenses Particulars Half Year Ended Rs . in Crores Year Ended 30.09.2021 ( Unaudited ) 30.06.2021 ( Unaudited ) 30.09.2020 ( Unaudited ) 30.09.2021 30.09.2020 ( Unaudited ) ( Unaudited ) 31.03.2021 ( Audited ) 1,292.32 1,326.03 1,457.10 2,618.35 2,798.41 5,393.13 2.20 1.88 3.22 4.08 3.54 10.02 1,294.52 1,327.91 1,460.32 2,622.43 2,801.95 5,403.14 4 ( a ) Cost of Materials consumed 248.94 288.91 324.14 537.85 581.38 1,185.35 ( b ) Purchase of stock - in - trade 78.39 115.79 71.62 194.18 120.88 265.92 ( c ) Changes in Inventories of finished goods , Stock in trade and WIP 5.56 ( 19.63 ) ( 83.77 ) ( 14.06 ) ( 52.50 ) ( 193.93 ) ( d ) Employee benefits expense 293.17 289.89 276.08 583.06 551.44 1,051.17 ( e ) Finance Costs 4.58 2.11 4.48 6.70 11.15 16.02 ( f ) Depreciation & Amortization Expense 54.60 53.15 43.78 107.75 85.28 183.47 ( g ) Other Expenses Total Expenses 409.03 1,094.28 415.14 1,145.37 5 Profit before tax 200.24 182.55 425.60 1,061.93 398.39 824.16 746.43 2,239.64 2,044.06 382.79 757.89 1,527.06 4,035.06 1,368.08 6 Tax Expense ( i ) Current Tax ( ii ) Deferred Tax 35.50 42.02 73.93 77.52 4.01 ( 7.82 ) ( 0.95 ) ( 3.81 ) 141.04 ( 1.29 ) 255.47 ( 9.56 ) 7.41 ( iii ) Short ( Excess ) Tax Provision 7 Profit for the Period before Share of Profit / ( Loss ) of Associates and Joint Ventures 160.73 148.35 325.42 309.08 618.15 1,114.76 8 Share of Profit / ( Loss ) of Associates & Joint Ventures 3.25 9.92 ( 0.16 ) 13.17 0.28 31.74 9 Net Profit after taxes and Share of Profit / ( Loss ) of Associates and Joint Ventures but before non - controlling interests 163.99 158.27 325.26 322.26 618.43 1,146.50 10 Non - controlling interests 5.31 6.25 8.12 11.55 16.40 31.61 11 Net Profit after taxes , non - controlling interests and share of Profit / ( Loss ) of Associates and Joint Ventures 169.29 164.52 333.37 333.81 634.83 1,178.11 12 Other Comprehensive Income A ( i ) Items that will not be reclassified to profit / ( loss ) 5.04 ( 5.49 ) ( 0.96 ) ( 0.45 ) ( 7.54 ) ( 1.25 ) ( ii ) Income tax relating to items that will not be reclassified to profit / ( loss ) ( 0.88 ) 0.95 0.16 0.07 1.30 0.19 B ( i ) Items that will be reclassified to profit / ( loss ) ( 0.31 ) 1.88 ( 1.85 ) 1.57 ( 2.13 ) ( 2.62 ) Total Other Comprehensive Income ( A + B ) 3.85 ( 2.66 ) ( 2.65 ) 1.20 ( 8.37 ) ( 3.69 ) 13 Total Comprehensive Income for the period ( 9 + 12 ) 167.84 155.61 322.60 323.45 610.06 1,142.81 Attributable to : - Non - controlling interests ( 5.30 ) - Owners of the Company 173.14 ( 6.27 ) 161.88 ( 8.15 ) 330.75 ( 11.57 ) 335.02 ( 16.44 ) 626.51 ( 31.69 ) 1,174.50 14 Earnings per share Basic & Diluted ( in Rs . ) . 8.61 8.37 17.24 16.98 33.25 60.81 15 Paid up Equity Share Capital ( Face Value of Rs 2 / - each ) 39.31 39.31 39.31 39.31 39.31 39.31 16 Other Equity 5,088.30 MEHTA VADODARA & CO . * CHARTERE COUNTANTS PHARMA TICALS VADODARA 390 003 ALEMBIC * SLIMITED